← Latest Filings
F

Fairmount Funds Management LLC

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
8
$79.0M total
Open-market sells
5
$1203.2M total
Tracking since
Oct 2025
Activity timeline
Open-market buy — $7.6M
CRESCENT BIOPHARMA, INC. · Jul 16, 2026
Open-market buy — $12.4M
CRESCENT BIOPHARMA, INC. · Jul 16, 2026
Open-market trades from the last two years.

11 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
6,911,174 Common Stock in CYCN
Held indirectly (By Fairmount Healthcare Fund II L.P.) · as of 2026-09-08
5,809,000 Common Stock in DMRA
Held indirectly (By Fairmount Healthcare Fund II L.P.) · as of 2026-02-09

18 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
Oruka Therapeutics, Inc.
CIK 0000907654
Alaunos Therapeutics, Inc.
CIK 0001107421

9 more companies. A free account shows you more; Premium shows every one.

Log in